No Detail Found!

Histomolecular Criteria to Differentiate Grade II/III Ependymoma with Aid of H3K27me3 and L1CAM Expression

Author(s)
Maher Kurdi Department of Pathology, Faculty of Medicine in Rabigh, King Abdulaziz University, Kingdom of Saudi Arabia
Riffat Mehboob Research unit, Faculty of Allied Health Sciences, Lahore Medical Research Center, LLP, Lahore, Pakistan
Saleh Baeesa Division of Neurosurgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
Yazid Maghrabi Department of Neuroscience, King Faisal Specialist Hospital, Jeddah, Kingdom of, Saudi Arabia
Sahar Hakamy Neuromuscular Unit, Center of Excellence in Genomic Medicine Research, Jeddah, King Abdulaziz University, Saudi Arabia
Alaa Alkhotani Department of Pathology, Faculty of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia
Bassam MJ. Addas Department of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Rana H Moshref Department of Pathology, Faculty of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia
Basem Bahakeem College of Medicine, Taibah University, Almadinah Almunawwarah, Saudi Arabia
Eyad Faizo Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Tabuk University, Tabuk, Saudi Arabia
Husam Malibary Department of Internal Medicine, Faculty of Medicine, King Abdul Aziz University, Jeddah, Saudi Arabia
Ahmed K. Bamaga Pediatric department, Neuromuscular Medicine Unit, Faculty of Medicine and King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia
Ahmed A Najjar College of Medicine, Taibah University, Almadinah Almunawwarah, Saudi Arabia
Yousef Katib Department of Radiology, Faculty of Medicine, Taibah University, Almadinah Almunawwarah, Saudi Arabia
Abstract
Ependymoma is a rare glial neoplasm of CNS with distinct histomolecular heterogenity. The current grading features are controversial, which affect prognosis. To establish unified histomolecular criteria to distinguish grade II/III ependymomas. The authors reviewed the features of 50 ependymomas. Different histological parameters were used to evaluate grading. Additional markers, L1CAM and H3K27me3, were incorporated into the scoring system. The previous grading were modified to new grading criteria. The mean age of the 50 cases was 10+12 years, with 70% of the tumors located in posterior fossa, and 30% in supratentorium. L1CAM was expressed in 10/15 of ST-EPN and 24/35 of PF-EPND showed loss of H3K27me3 expression. All histological features that help differentiate grade II/III ependymomas revealed significant differences and indicating that single histological feature should not be solely used for grading. A significant difference in recurrence between grade II/III ependymomas was noted (P=0.009). These results indicated that a score of = 10 is considered grade III. There was a significant difference in tumor grading using the previous and new grading methods. All 25 ependymoma cases that were classified as grade II remained as grade II with the new grading system, while 24% of cases previously classified as grade III were reclassified as grade II.The final phase of this study employed novel histomolecular criteria for grading intracranial ependymoma based on a fixed scoring system. This scoring-grading system must be used in further studies to confirm its accuracy.
Publication Details
Page(s) 295-304
DOI DOI not available
Published Journal: Bioscience Research, Volume: 19, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
Ependymoma, Grading, L1CAM, H3K27me3, Histological features
0

Citations

0

Downloads

41

Views